Medrx Co (TSE:4586) E10: 円0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4586 Medrx Co Ltd TSE:4586
57 GF Score
Price 円57.00
GF Value 円70.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medrx Co E10?

Medrx Co TSE:4586 +3.64% 57 E10 is 円0.00 as of Dec. 2025. GuruFocus rates TSE:4586 with a GF Score™ of 57/100 and a GF Value™ of 円70.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medrx Co's adjusted earnings per share data for the three months ended in Dec. 2025 was 円0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円0.00 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-15), Medrx Co's current stock price is 円57.00. Medrx Co's E10 for the quarter that ended in Dec. 2025 was 円0.00. Medrx Co's Shiller PE Ratio of today is .


Medrx Co  (TSE:4586) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medrx Co E10 Related Terms


Medrx Co E10 Historical Data

* Premium members only.

The historical data trend for Medrx Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medrx Co E10 Chart

Medrx Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -114.50 -107.30 0.00 0.00

Medrx Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -97.82 -96.38 0.00 0.00

TSE:4586 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Shiller PE Ratio falls into.


TSE:4586
57GF Score
Medrx Co Ltd TSE:4586
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medrx Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medrx Co's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0/113.0000*113.0000
=0.000

Current CPI (Dec. 2025) = 113.0000.

Medrx Co Quarterly Data

per share eps CPI Adj_EPS
201509 -29.120 98.500 -33.407
201512 -51.770 98.100 -59.633
201603 -33.330 97.900 -38.471
201606 -58.770 98.100 -67.696
201609 -33.945 98.000 -39.141
201612 -30.837 98.400 -35.412
201703 -22.610 98.100 -26.044
201706 -33.510 98.500 -38.443
201709 -27.530 98.800 -31.487
201712 -19.510 99.400 -22.179
201803 -31.130 99.200 -35.461
201806 -27.380 99.200 -31.189
201809 -36.270 99.900 -41.026
201812 -32.060 99.700 -36.337
201903 -45.010 99.700 -51.014
201906 -32.130 99.800 -36.380
201909 -25.847 100.100 -29.178
201912 -32.440 100.500 -36.475
202003 -20.930 100.300 -23.580
202006 -26.180 99.900 -29.613
202009 -15.950 99.900 -18.042
202012 -6.866 99.300 -7.813
202103 -13.370 99.900 -15.123
202106 -10.570 99.500 -12.004
202109 -8.990 100.100 -10.149
202112 -16.690 100.100 -18.841
202203 -8.010 101.100 -8.953
202206 -7.490 101.800 -8.314
202209 -10.320 103.100 -11.311
202212 -17.990 104.100 -19.528
202303 -9.610 104.400 -10.402
202306 -5.438 105.200 -5.841
202309 -5.030 106.200 -5.352
202312 -6.820 106.800 -7.216
202403 -3.330 107.200 -3.510
202406 1.531 108.200 1.599
202412 0.000 110.700 0.000
202503 -9.040 111.100 -9.195
202506 -3.780 111.700 -3.824
202512 0.000 113.000 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円0.00 mean?
Medrx Co (TSE:4586) has a E10 of 円0.00 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medrx Co and its competitors.
Is Medrx Co's E10 too high?
Medrx Co's current E10 is 円0.00. Overall, Medrx Co has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medrx Co's E10 compare to ZTS and UTHR?
Medrx Co's E10 of 円0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medrx Co and its competitors. Medrx Co's current E10 is 円0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medrx Co stock overvalued right now?
Based on GuruFocus' analysis, Medrx Co (TSE:4586) is currently considered Modestly Undervalued. The stock's GF Value™ is 円70.55, compared to a current price of 円57.00 — trading 19.2% below its estimated fair value. The current E10 is 円0.00. Medrx Co's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medrx Co (TSE:4586), the current E10 is 円0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medrx Co (TSE:4586) Overvalued in 2026?

Based on GuruFocus' analysis, Medrx Co stock appears to be undervalued. The current stock price of 円57.00 is trading 19.2% below its estimated GF Value™ of 円70.55. GuruFocus considers Medrx Co to be Modestly Undervalued.

Key valuation signals for TSE:4586:

  • E10: 円0.00
  • GF Value™: 円70.55 vs. price of 円57.00 (19.2% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the TSE:4586 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medrx Co Business Description

Address 431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.
57GF Score

Get the complete analysis for TSE:4586

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円57.00
Price
円70.55
GF Value